- Home
- JANX vs HTZ Comparison
JANX vs HTZ Comparison
Compare JANX & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- HTZ
- Stock Information
- Founded
- JANX 2017
- HTZ 1918
- Country
- JANX United States
- HTZ United States
- Employees
- JANX N/A
- HTZ N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- HTZ Rental/Leasing Companies
- Sector
- JANX Health Care
- HTZ Consumer Discretionary
- Exchange
- JANX Nasdaq
- HTZ Nasdaq
- Market Cap
- JANX 1.7B
- HTZ 2.1B
- IPO Year
- JANX 2021
- HTZ 1997
- Fundamental
- Price
- JANX $29.41
- HTZ $5.72
- Analyst Decision
- JANX Strong Buy
- HTZ Hold
- Analyst Count
- JANX 10
- HTZ 3
- Target Price
- JANX $77.40
- HTZ $4.90
- AVG Volume (30 Days)
- JANX 1.1M
- HTZ 18.0M
- Earning Date
- JANX 11-06-2025
- HTZ 11-04-2025
- Dividend Yield
- JANX N/A
- HTZ N/A
- EPS Growth
- JANX N/A
- HTZ N/A
- EPS
- JANX N/A
- HTZ N/A
- Revenue
- JANX $10,000,000.00
- HTZ $8,516,000,000.00
- Revenue This Year
- JANX N/A
- HTZ N/A
- Revenue Next Year
- JANX $89.91
- HTZ $2.37
- P/E Ratio
- JANX N/A
- HTZ N/A
- Revenue Growth
- JANX N/A
- HTZ N/A
- 52 Week Low
- JANX $21.73
- HTZ $3.15
- 52 Week High
- JANX $71.71
- HTZ $9.39
- Technical
- Relative Strength Index (RSI)
- JANX 58.15
- HTZ 47.94
- Support Level
- JANX $26.96
- HTZ $6.01
- Resistance Level
- JANX $29.53
- HTZ $6.85
- Average True Range (ATR)
- JANX 2.10
- HTZ 0.57
- MACD
- JANX 0.00
- HTZ 0.06
- Stochastic Oscillator
- JANX 67.36
- HTZ 39.41
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About HTZ Hertz Global Holdings Inc
Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.